Navigation Links
Reportlinker Adds Cardiovascular Surgical Devices: The Global Market
Date:11/9/2010

NEW YORK, Nov. 9, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiovascular Surgical Devices: The Global Market

http://www.reportlinker.com/p0326193/Cardiovascular-Surgical-Devices-The-Global-Market.html

The global market for cardiovascular surgical devices used in the operating room is worth an estimated $31 billion in 2010. By 2015, this market will be valued at nearly $48 billion, a compound annual growth rate (CAGR) of 8.7%.

Despite significant growth in interventional cardiac surgery procedures, the traditional cardiac surgical device market is expected to expand faster, primarily driven by the growth in cardioprosthetics such as ventricular assist devices. This sector is worth an estimated $7 billion in 2010 and is expected to increase at a 10.9% compound annual growth rate (CAGR) to reach $12 billion in 2015.

The second fastest area of growth is in cardiac rhythm management devices, particularly for the treatment of atrial fibrillation (AF). This sector is valued at $11 billion in 2010 and is expected to be worth $18 billion in 2015, a compound annual growth rate (CAGR) of 10.2%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The goal of this study is to explore the different factors affecting cardiovascular surgery and the manufacture of cardiovascular devices. Cardiac surgery is on the rise globally, with macroeconomic factors such as aging populations; increased obesity, poor nutrition, and other heart-health stressors; and the technological maturity of devices that make sophisticated treatments feasible for patients in previously inaccessible populations.

Whether through disease, congenital defects, or generalized degradation of cardiological function over time, cardiovascular diseases are increasing dramatically, substantiating the need for continued growth of cardiovascular surgery.

REASONS FOR DOING THIS STUDY

According to statistics from the American Medical Association (AMA), more than 80 million people suffer from some form of heart disease. While cardiovascular surgery has long been practiced, recent innovations such as minimally invasive procedures, "beating heart" surgeries, cardiac rhythm management (CRM), and other procedural improvements have become treatments that create fewer side effects for patients and less time spent in post-surgical recovery.

Newer cardiovascular devices and procedures play a large part in enhancing the quality of life for an increasingly elderly population, as well as populations with poor cardiac function and other heart-related diseases. The ability of government-run health agencies and private insurers to cope with the increasing need for cardiovascular procedures and the skyrocketing costs involved have lead agencies and insurers alike to consider their payments surrounding necessary medical procedures and, consequently, cardiovascular surgical procedures.

This report will identify areas of growth within the cardiovascular surgical equipment market and identify companies offering innovative equipment relating to cardiovascular devices. Growth will be projected on manufacturers' net revenues, unless otherwise indicated.

This report is designed to achieve the following objectives: 

Describe the trends and developments for each type of cardiovascular surgical technology and how each is meant to meet marketplace needs.

Analyze market and driving forces to project market size for the technologies and pinpoint target applications.

Examine the cardiovascular surgical business in terms of companies and their position in the market.

The report is designed to appeal to many different readers, including venture capitalists interested in exploring commercialization opportunities, marketing, and management individuals within the industry, and even the novice reader, who desires to understand how market pressures and technology interact in this industry.

SCOPE OF REPORT

The scope of this study encompasses multiple technologies and procedures related to cardiovascular surgical devices. The study focuses on several different types and categories of cardiovascular surgery involving traditional, interventional, and CRM devices, categorized logically so that comparisons can be made within diagnostic and procedural groups as well as across the cardiovascular surgical device industry as a whole.

BCC analyzes the industry on a worldwide basis from market, product, and technology perspectives. Regulations and reimbursement issues and patents issued from 2005 to 2010 are also examined to identify consumer safety, product INTRODUCTION, and product safety regulatory issues for stakeholders and potential stakeholders in this industry.

The report examines the cardiovascular surgery equipment industry in general, the types of technology currently in use as well as future applications, and regulatory influences. The industry structure section discusses the most active manufacturers with regard to relative market share, marketing strengths, and forces that promote or hamper growth of technologies. The technology sections detail historical, current, and projected (2010 through 2015) market values.

METHODOLOGY

BCC presents an analysis across the entire cardiovascular surgical device market based on reported revenue dollars and units shipped as reported to the Securities and Exchange Commission (SEC) and/or other governmental agencies, as well as company information such as annual reports and product/financial news releases.

We also analyze data gathered from the United States Patent Office (USPTO) databases. Technological and demographic information is gathered from industry sources, governmental sources, and published news reports.

INFORMATION SOURCES

BCC conducted primary and secondary research to develop this report. Sources included companies in the cardiovascular device market and supply industry, public documents, SEC filings, corporate white papers, and other technical documentation for U.S. and international companies directly involved in manufacturing and distributing of cardiovascular devices and related equipment. The report excludes resellers and retailers, focusing rather on the primary companies responsible for the development of the underlying technology.

Where precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data.

Chapter- 1: INTRODUCTION

STUDY GOALS AND OBJECTIVES 1

REASONS FOR DOING THIS STUDY 1

SCOPE OF REPORT 2

METHODOLOGY 2

INFORMATION SOURCES 3

ANALYST CREDENTIALS 3

RELATED BCC PUBLICATIONS 3

BCC ONLINE SERVICES 3

DISCLAIMER 4

Chapter-2: SUMMARY

SUMMARY TABLE GLOBAL MARKET FOR CARDIOVASCULAR SURGICAL DEVICES, THROUGH 2015 ($ MILLIONS) 5

SUMMARY FIGURE CARDIOVASCULAR SURGICAL DEVICES BY TYPE, 2010 AND 2015 (%) 6

Chapter-3: OVERVIEW OF THE INDUSTRY

GLOBAL INCIDENCES OF CARDIAC DISEASE 7

CARDIAC DISEASE IN DEVELOPED COUNTRIES 7

CARDIAC DISEASE IN DEVELOPING COUNTRIES 8

HISTORY OF CARDIOVASCULAR SURGERY 8

INDUSTRY CONSOLIDATION 9

TABLE 1 SELECTED ACQUISITIONS AND MERGERS, 2001–2010 ($ MILLIONS) 9

RISKS ASSOCIATED WITH CARDIAC SURGERY 9

TYPES OF SURGERIES 10

TRADITIONAL CARDIAC SURGERY 10

OPEN HEART SURGERY 10

Objectives 10

Risks 11

TABLE 2 LEADING MANUFACTURERS OF OPEN HEART SURGICAL DEVICES 11

CARDIOPULMONARY BYPASS GRAFT SURGERY 11

Objectives 11

Risks 12

TABLE 3 LEADING MANUFACTURERS OF CABG SURGICAL DEVICES 12

BEATING HEART SURGERY (OFF-PUMP BYPASS SURGERY) 12

Objectives 12

Risks 12

TABLE 4 LEADING MANUFACTURERS OF BEATING HEART SURGICAL DEVICES 13

TRANSMYOCARDIAL REVASCULARIZATION 13

Objectives 13

Risks 13

TABLE 5  LEADING MANUFACTURERS OF TMR SYSTEMS 13

CARDIOPROSTHETICS 14

Objectives 14

Risks 14

TABLE 6 LEADING MANUFACTURERS OF CARDIOPROSTHETICS SURGICAL DEVICES 14

TABLE 6 (CONTINUED) 15

FIGURE 1 GLOBAL MARKET LEADERS IN TRADITIONAL CARDIAC SURGICAL DEVICES, 2009 (%) 15

FIGURE 1 (CONTINUED) 16

INTERVENTIONAL CARDIAC SURGERY 16

MIDCAB 16

Objectives 17

Risks 17

TABLE 7 LEADING MANUFACTURERS OF INTERVENTIONAL CARDIAC SURGERY DEVICES 17

TABLE 7 (CONTINUED) 18

ENDOSCOPIC CARDIOVASCULAR SURGERY 18

Objectives 18

Risks 18

PLAQUE REMOVAL SURGERY 18

Angioplasty 19

Objectives 19

Risks 19

TABLE 8 LEADING MANUFACTURERS OF ANGIOPLASTY DEVICES 19

Atherectomy 20

Objectives 20

Risks 20

TABLE 9 LEADING MANUFACTURERS OF PLAQUE REMOVAL DEVICES 20

Laser Angioplasty 20

Objective 21

Risks 21

Stent Procedure 21

Objectives 21

Risk 22

TABLE 10 LEADING MANUFACTURERS OF CARDIAC STENTS 22

FIGURE 2 MARKET SHARES HELD BY LEADERS IN DES, 2009 (%) 23

Cardiomyoplasty 23

Objectives 23

Risks 24

Robotic-assisted Heart Surgery 24

Objectives 24

Risks 25

Vascular Surgery 25

Objective 25

Risks 25

MARKET LEADERS IN INTERVENTIONAL CARDIAC SURGERY 25

FIGURE 3 GLOBAL MARKET LEADERS IN INTERVENTIONAL CARDIAC SURGICAL DEVICES, 2009 (%) 26

CRM SURGERY 26

Cardiac Ablation for Rhythm Management 27

TABLE 11 LEADING MANUFACTURERS OF CARDIAC ABLATION DEVICES TO PROMOTE CRM 27

Pacemakers 27

Objective 27

Risks 28

TABLE 12 LEADING MANUFACTURERS OF CARDIAC PACEMAKERS 28

Defibrillators 28

Objective 28

Risk 29

TABLE 13 LEADING MANUFACTURERS OF CARDIAC DEFIBRILLATORS 29

Catheters 29

Objective 29

Risks 29

TABLE 14 LEADING MANUFACTURERS OF CRM CATHETERS 30

Market Leaders 30

FIGURE 4 GLOBAL MARKET LEADERS IN CARDIAC RHYTHM MANAGEMENT SURGICAL DEVICES, 2009 (%) 31

Chapter-4: GLOBAL IMPLICATIONS OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR SURGERY

CORONARY HEART DISEASE IN DEVELOPED NATIONS 32

CORONARY HEART DISEASE IN DEVELOPING COUNTRIES 33

PRIMARY RISK FACTORS IN CVD 33

ECONOMIC CONSEQUENCES OF CVD 33

TABLE 15 LEADING CAUSES OF HEART FAILURE, 2002–2006 (%) 34

U.S. MARKET 34

POPULATION 34

TABLE 16 HEART DISEASE IN THE U.S., 2006 (MILLIONS) 35

LEADING CARDIOVASCULAR SURGICAL CENTERS 35

TABLE 17 LEADING CARDIOVASCULAR SURGERY CENTERS, U.S., 2010 35

EUROPEAN MARKET 35

TYPES OF CARDIOVASCULAR SURGERIES PERFORMED 36

ECONOMIC BURDEN OF CVD IN THE EU 36

LEADING CARDIOVASCULAR SURGICAL CENTERS 36

TABLE 18 LEADING CARDIOVASCULAR SURGERY CENTERS IN BRITAIN, 2006 36

THE EU 27 AND EASTERN EUROPE 37

COST AND VALUE EVALUATION 37

JAPAN 37

LEADING CARDIOVASCULAR SURGICAL CENTERS 38

TABLE 19 LEADING CARDIOVASCULAR SURGERY CENTERS IN JAPAN, 2006 38

CHINA 38

TABLE 20 LEADING CARDIOVASCULAR SURGERY CENTERS IN CHINA, 2003 39

INDIA 39

LEADING CARDIOVASCULAR SURGICAL CENTERS 39

TABLE 21 LEADING CARDIOVASCULAR SURGERY CENTERS IN INDIA, 2010 40

REST OF THE WORLD 40

IMPLICATIONS FOR CARDIOVASCULAR SURGERY 40

TABLE 22 SELECTED WORLDWIDE CORONARY PROCEDURES, 2008 (PER 100,000 POPULATION) 41

FIGURE 5 PERCENTAGE OF MARKET BY GEOGRAPHICAL AREA, 2010 (%) 42

IMPLICATIONS FOR TRADITIONAL CARDIAC SURGERY 42

Market Strengths 43

Market Weaknesses 43

Opportunities 43

Threats 43

IMPLICATIONS FOR INTERVENTIONAL CARDIAC SURGERY 43

Strengths 44

Weaknesses 44

Opportunities 44

Threats 44

IMPLICATIONS FOR CRM SURGERY 44

Strengths 45

Weaknesses 45

Opportunities 45

Threats 45

Chapter-5: GLOBAL MARKET FOR TRADITIONAL CARDIAC SURGERY DEVICES

TABLE 23 GLOBAL VALUE OF TRADITIONAL CARDIAC SURGERY DEVICES, THROUGH 2015 ($ MILLIONS) 46

OPEN HEART SURGERY 47

BYPASS SURGERY 47

TABLE 24 PROJECTED GLOBAL MARKET FOR OPEN HEART AND CABG-RELATED SURGICAL DEVICES, THROUGH 2015 ($ MILLIONS) 48

BEATING HEART SURGERY 48

BEATING HEART SURGERY (CONTINUED) 49

TABLE 25 GLOBAL REVENUES FROM BEATING HEART SURGICAL DEVICES, THROUGH 2015 ($ MILLIONS) 50

NEW DEVICES 50

TRANSMYOCARDIAL REVASCULARIZATION 50

TABLE 26 GLOBAL MARKET FOR TMR DEVICES, THROUGH 2015 ($ MILLIONS) 51

CARDIOPROSTHETIC SURGERY 51

VAD MARKET 52

TABLE 27 GLOBAL MARKET FOR CARDIOPROSTHETICS DEVICES, THROUGH 2015 ($ MILLIONS) 53

TOTAL ARTIFICIAL HEARTS 53

AbioMed 53

SynCardia 53

TABLE 28 GLOBAL MARKET FOR TOTAL ARTIFICIAL HEARTS, THROUGH 2015 ($ MILLIONS) 54

VENTRICULAR ASSIST DEVICES 54

Regeneration Instead of Replacement 54

TABLE 29 GLOBAL MARKET FOR VADS, THROUGH 2015 ($ MILLIONS) 55

VAD as Destination Therapy 55

HEART VALVES 56

Advantages/Disadvantages of Mechanical, Biological, and Homograft Heart Valves 56

Mechanical 56

Biological/Tissue 56

Homograft 57

The Market for Valves 57

TABLE 30 GLOBAL HEART VALVE MARKET, THROUGH 2015 ($ MILLIONS) 57

TABLE 31 LEADING HEART VALVE SUPPLIERS, 2009 ($ MILLIONS) 58

HEART VALVE MARKET IN THE FUTURE 58

Chapter-6: INTERVENTIONAL CARDIAC SURGERY DEVICES

INTERVENTIONAL CARDIAC SURGERY DEVICES 59

TABLE 32 GLOBAL MARKET FOR INTERVENTIONAL CARDIAC SURGERY DEVICES, THROUGH 2015 ($ MILLIONS) 60

PERCUTANEOUS CORONARY INTERVENTION 60

TABLE 33 GLOBAL MARKET FOR PCI CATHETERS, THROUGH 2015 ($ MILLIONS) 61

DRAWBACK OF PCI 61

LEADING MANUFACTURERS 61

FIGURE 6 MARKET LEADERS IN PCI CATHETER SALES BY COMPANY, 2009 (%) 62

STENTS 62

TABLE 34 PROJECTED GLOBAL MARKET FOR STENTS, THROUGH 2015 ($ MILLIONS) 63

FIGURE 7 GLOBAL MARKET SHARES FOR STENTS BY REGION, 2009 (%) 64

MARKET COMPETITION 64

VALVULOPLASTY 65

VALVE REPLACEMENT VIA CATHETER 65

TRANSCATHETER AORTIC VALVES 65

CARDIAC ABLATION 66

THROMBECTOMY 66

CRYOABLATION 66

RF ABLATION 67

ABLATION DEVICE MANUFACTURERS 67

TABLE 35 GLOBAL MARKET FOR CARDIAC ABLATION DEVICES, THROUGH 2015 ($ MILLIONS) 67

CARDIOVASCULAR ROBOTIC SURGERY 67

TABLE 36 GLOBAL MARKET FOR CARDIOVASCULAR ROBOTIC SURGERY DEVICES, THROUGH 2015 ($ MILLIONS) 68

Chapter-7: GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES

ARRHYTHMIAS 69

CAUSES OF ARRHYTHMIAS 69

ATRIAL FIBRILLATION 69

AF TREATMENTS 69

LEFT ATRIAL APPENDAGE OCCLUSION 70

Watchman Occluder 70

Amplatzer Device 71

CRM GLOBAL MARKET 71

TABLE 37 PROJECTED GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, THROUGH 2015 ($ MILLIONS) 72

PACEMAKERS 72

TABLE 38 PROJECTED GLOBAL MARKET FOR PACEMAKERS, THROUGH 2015 ($ MILLIONS) 73

FIGURE 8 MARKET POSITION FOR LEADING MANUFACTURERS OF PACEMAKERS (%) 73

DEFIBRILLATORS 74

TABLE 39 PROJECTED GLOBAL MARKET FOR IMPLANTABLE DEFIBRILLATORS, THROUGH 2015 ($ MILLIONS) 74

FIGURE 9 MARKET SHARE OF LEADING MANUFACTURERS OF IMPLANTABLE DEFIBRILLATORS, 2010 74

FIGURE 9 (CONTINUED) 75

ELECTROPHYSIOLOGY CATHETERS 75

TABLE 40 PROJECTED GLOBAL VALUE OF OTHER CRM DEVICES, 2010–2015 ($ MILLIONS) 76

ABLATION CATHETERS FOR TREATING AF 76

Chapter-8: ONGOING DEVELOPMENT OF CARDIOVASCULAR DEVICES/TREATMENTS

TRADITIONAL CARDIAC SURGERY 77

HEART-LUNG DEVICES 77

Maquet 77

LVAD 78

TABLE 41 LEFT VENTRICULAR ASSIST DEVICES IN DEVELOPMENT 78

OTHER CARDIAC ASSIST DEVICES IN DEVELOPMENT 78

Sunshine Heart 79

INTERVENTIONAL CARDIAC SURGERY 79

STENTS 79

Conor MedSystems 79

Biotronik/Abbott Vascular 80

OrbusNeich 80

Abbott Vascular 80

Medtronic 81

NEOANGIOGENESIS 81

HEART VALVES 82

Abbott Vascular 82

University of Michigan 82

National Heart, Lung, and Blood Institute Clinical Trials 82

CARDIAC SUPPORT DEVICES 83

Passive Support Systems 83

Acorn Cardiovascular 83

Paracor Medical 83

University of Leeds 84

CARDIAC RHYTHM MANAGEMENT 84

CYBERKNIFE 84

HEMODYNAMIC MONITORS 85

CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS 85

Chapter-9: REIMBURSEMENT AND REGULATION ISSUES

REIMBURSEMENT 86

UNITED STATES 86

CMS Proposed Reimbursement Rates for 2011 87

CMS Reimbursement for ICDs 87

Proposed "Bundling" of Services 88

EUROPEAN UNION 89

CHINA 89

Centralized Tendering Proposals 90

JAPAN 90

REGULATIONS 91

UNITED STATES 91

Permission to Distribute a Device 92

FDA Export Requirements 93

Newer Regulations 93

Reclassification of PTCA Devices 94

U.S. Cardiovascular Surgical Device Recalls: 2005–2010 94

TABLE 42 U.S. CARDIOVASCULAR SURGICAL DEVICE RECALLS, 2005–2009 94

DIFFERENCES IN EUROPEAN AND U.S. REGULATIONS 95

EUROPEAN UNION 95

CHINA 96

Additional Incentives for Local Manufacturers 96

JAPAN 97

Costs of Gaining Approval in Japan 97

Chapter-10: PATENT ANALYSIS

CARDIAC RHYTHM MANAGEMENT 98

PACEMAKERS 98

TABLE 43 U.S. PATENTS ISSUED FOR CARDIAC PACEMAKER EQUIPMENT, JUNE 2006-AUGUST 2010 98

TABLE 43 (CONTINUED) 99

DEFIBRILLATORS 99

TABLE 44 U.S. PATENTS ISSUED FOR CARDIAC DEFIBRILLATOR EQUIPMENT, APRIL 2009-AUGUST 2010 100

STENTS 101

TABLE 45 U.S. PATENTS ISSUED FOR CARDIAC STENT EQUIPMENT, JUNE 2007-JULY 2010 101

CATHETERS 102

TABLE 46 U.S. PATENTS ISSUED FOR CARDIAC CATHETER EQUIPMENT, DECEMBER 2005-AUGUST 2010 102

TABLE 46 (CONTINUED) 103

TABLE 46 (CONTINUED) 104

ELECTROPHYSIOLOGY EQUIPMENT 104

TABLE 47 U.S. PATENTS ISSUED FOR ELECTROPHYSIOLOGY EQUIPMENT, OCTOBER 2006-JULY 2010 104

TABLE 47 (CONTINUED) 105

CARDIAC VALVES 105

TABLE 48 U.S. PATENTS ISSUED FOR CARDIAC VALVE SURGERY, FEBRUARY 2007-AUGUST 2010 105

TABLE 48 (CONTINUED) 106

OTHER CARDIAC SURGERY EQUIPMENT 106

TABLE 49 U.S. PATENTS ISSUED FOR OTHER CARDIAC SURGERY EQUIPMENT, JANUARY 2005-AUGUST 2010 106

TABLE 49 (CONTINUED) 107

TABLE 49 (CONTINUED) 108

TABLE 49 (CONTINUED) 109

BY YEAR 109

TABLE 50 U.S. CARDIOVASCULAR SURGICAL DEVICES BY YEAR, JANUARY 2005-AUGUST 2010 (NUMBER) 110

FIGURE 10 U.S. CARDIOVASCULAR SURGICAL DEVICES BY TYPE, 2005–2010 (%) 110

FIGURE 10 (CONTINUED) 111

BY ASSIGNEE 111

TABLE 51 U.S. CARDIOVASCULAR SURGICAL DEVICE PATENTS BY ASSIGNEE (NUMBER) 111

TABLE 51 (CONTINUED) 112

Chapter-11: COMPANY DIRECTORY

ABBOTT CARDIOVASCULAR 113

BUSINESS OVERVIEW 113

FINANCIALS 113

PRODUCTS 114

TABLE 52 ABBOTT VASCULAR CARDIOVASCULAR SURGICAL PRODUCTS 114

ABIOMED, INC. 115

BUSINESS OVERVIEW 115

FINANCIALS 115

PRODUCTS 115

TABLE 53 ABIOMED CARDIOVASCULAR SURGICAL PRODUCTS 116

ABLATION FRONTIERS (MEDTRONIC) 116

BUSINESS OVERVIEW 116

FINANCIALS 116

PRODUCTS 117

TABLE 54 ABLATION FRONTIERS CARDIOVASCULAR SURGICAL PRODUCTS 117

ANGIODYNAMICS, INC. 117

BUSINESS OVERVIEW 117

FINANCIALS 117

PRODUCTS 118

TABLE 55 ANGIODYNAMICS CARDIOVASCULAR CATHETER PRODUCTS 118

ARROW INTERNATIONAL (TELEFLEX) 118

BUSINESS OVERVIEW 118

FINANCIALS 118

PRODUCTS 119

TABLE 56 ARROW INTERNATIONAL CARDIOVASCULAR CATHETER PRODUCTS 119

BECTON DICKINSON AND CO. 119

BUSINESS OVERVIEW 119

FINANCIALS 119

PRODUCTS 120

TABLE 57 BECTON DICKINSON CARDIOVASCULAR SURGICAL PRODUCTS 120

BERLIN HEART AG 120

BERLIN HEART U.S. OFFICE 120

BUSINESS OVERVIEW 120

FINANCIALS 121

PRODUCTS 121

TABLE 58 BERLIN HEART CARDIOVASCULAR SURGICAL PRODUCTS 121

BIOCARDIA, INC. 121

BUSINESS OVERVIEW 121

FINANCIALS 122

PRODUCTS 122

TABLE 59 BIOCARDIA CARDIOVASCULAR SURGICAL PRODUCTS 122

BIOSENSE WEBSTER, INC. 122

BUSINESS OVERVIEW 122

FINANCIALS 123

PRODUCTS 123

TABLE 60 BIOSENSE WEBSTER CARDIOVASCULAR SURGICAL PRODUCTS 123

BIOTRONIK GMBH 124

BUSINESS OVERVIEW 124

FINANCIALS 124

PRODUCTS 124

TABLE 61 BIOTRONIK CARDIOVASCULAR SURGICAL PRODUCTS 125

BLUE MEDIAL DEVICES 125

BUSINESS OVERVIEW 125

FINANCIALS 125

PRODUCTS 125

TABLE 62 BLUE MEDICAL CARDIOVASCULAR SURGICAL PRODUCTS 126

BOSTON SCIENTIFIC CORP. 126

BUSINESS OVERVIEW 126

FINANCIALS 127

PRODUCTS 127

TABLE 63 BOSTON SCIENTIFIC CARDIOVASCULAR SURGICAL PRODUCTS 128

B. BRAUN MELSUNGEN AG 129

BUSINESS OVERVIEW 129

FINANCIALS 129

PRODUCTS 129

TABLE 64 B. BRAUN CARDIOVASCULAR CATHETER PRODUCTS 129

C.R. BARD, INC. 130

BUSINESS OVERVIEW 130

FINANCIALS 130

PRODUCTS 130

TABLE 65 C.R. BARD CARDIOVASCULAR CATHETER PRODUCTS 131

CARDIAC ASSIST, INC. 131

BUSINESS OVERVIEW 131

FINANCIALS 132

PRODUCTS 132

TABLE 66 CARDIACASSIST CARDIOVASCULAR PRODUCTS 132

CARDIMA, INC. 132

BUSINESS OVERVIEW 132

FINANCIALS 132

PRODUCTS 133

TABLE 67 CARDIMA CARDIOVASCULAR PRODUCTS 133

CARDIOGENESIS CORP. 133

BUSINESS OVERVIEW 133

FINANCIALS 133

PRODUCTS 134

TABLE 68 CARDIOGENESIS CARDIOVASCULAR PRODUCTS 134

COOK MEDICAL 134

BUSINESS OVERVIEW 134

FINANCIALS 135

PRODUCTS 135

TABLE 69 COOK MEDICAL CARDIOVASCULAR CATHETER PRODUCTS 135

CORDIS CORP. 136

BUSINESS OVERVIEW 136

FINANCIALS 136

PRODUCTS 136

TABLE 70 CORDIS CARDIOVASCULAR SURGERY PRODUCTS 137

CRYOLIFE, INC. 137

BUSINESS OVERVIEW 137

FINANCIAL 138

PRODUCT 138

TABLE 71 CRYOLIFE CARDIOVASCULAR SURGERY PRODUCTS 138

EDWARDS LIFESCIENCE CORP. 139

BUSINESS OVERVIEW 139

FINANCIALS 139

PRODUCTS 140

TABLE 72 EDWARDS LIFESCIENCES CARDIOVASCULAR PRODUCTS 140

HEARTWARE INTERNATIONAL, INC. 140

BUSINESS OVERVIEW 140

FINANCIALS 141

PRODUCTS 141

TABLE 73 HEARTWARE CARDIOVASCULAR PRODUCTS 141

INTUITIVE SURGICAL 141

BUSINESS OVERVIEW 141

FINANCIALS 142

PRODUCTS 142

TABLE 74 INTUITIVE SURGICAL CARDIOVASCULAR PRODUCTS 143

JARVIK HEART, INC. 143

BUSINESS OVERVIEW 143

FINANCIALS 143

PRODUCTS 143

TABLE 75 JARVIK HEART CARDIOVASCULAR PRODUCTS 144

MAQUET CARDIOVASCULAR (DATASCOPE) 144

BUSINESS OVERVIEW 144

FINANCIALS 144

PRODUCTS 145

TABLE 76 MAQUET CARDIOVASCULAR PRODUCTS 145

MEDTRONIC 145

BUSINESS OVERVIEW 145

FINANCIALS 146

PRODUCTS 146

TABLE 77 MEDTRONIC CARDIOVASCULAR SURGICAL PRODUCTS 146

TABLE 77 (CONTINUED) 147

MERIT MEDICAL SYSTEMS, INC. 147

BUSINESS OVERVIEW 147

FINANCIALS 148

PRODUCTS 148

TABLE 78 MERIT MEDICAL CARDIOVASCULAR SURGICAL PRODUCTS 148

MICROMED TECHNOLOGY, INC. 148

BUSINESS OVERVIEW 148

FINANCIALS 148

PRODUCTS 149

TABLE 79 MICROMED CARDIOVASCULAR SURGICAL PRODUCTS 149

NMT MEDICAL 149

BUSINESS OVERVIEW 149

FINANCIALS 149

PRODUCTS 150

TABLE 80 NMT CARDIOVASCULAR SURGICAL PRODUCTS 150

NUMED, INC. 150

BUSINESS OVERVIEW 150

FINANCIALS 150

PRODUCTS 151

TABLE 81 NUMED CARDIOVASCULAR SURGICAL PRODUCTS 151

ORBUSNEICH 151

BUSINESS OVERVIEW 151

FINANCIALS 152

PRODUCTS 152

TABLE 82 ORBUSNEICH CARDIOVASCULAR SURGICAL PRODUCTS 152

ON-X LIFE TECHNOLOGIES, INC. 153

TABLE 83 ON-X LIFE TECHNOLOGIES CARDIOVASCULAR SURGICAL PRODUCTS 153

PLC MEDICAL SYSTEMS 153

BUSINESS OVERVIEW 153

FINANCIALS 154

PRODUCTS 154

TABLE 84 PLC MEDICAL SYSTEMS TMR SURGICAL SYSTEMS 154

SORIN GROUP, SPA 154

BUSINESS OVERVIEW 155

FINANCIALS 155

PRODUCTS 156

TABLE 85 SORIN GROUP CARDIOVASCULAR SURGICAL PRODUCTS 156

SPECTRANETICS 156

BUSINESS OVERVIEW 156

FINANCIALS 157

PRODUCTS 157

TABLE 86 SPECTRANETICS CARDIOVASCULAR SURGICAL PRODUCTS 157

ST. JUDE MEDICAL 157

BUSINESS OVERVIEW 157

FINANCIALS 158

PRODUCTS 158

TABLE 87 ST. JUDE MEDICAL CARDIOVASCULAR SURGICAL PRODUCTS 159

SYNCARDIA SYSTEMS, INC. 160

BUSINESS OVERVIEW 160

FINANCIALS 160

PRODUCTS 160

TABLE 88 SYNCARDIA CARDIOVASCULAR SURGICAL PRODUCTS 160

TERUMO MEDICAL CORP. 160

BUSINESS OVERVIEW 161

FINANCIALS 161

PRODUCTS 161

TABLE 89 TERUMO CARDIOVASCULAR SURGICAL PRODUCTS 161

TABLE 89 (CONTINUED) 162

THORATEC LABORATORIES 162

BUSINESS OVERVIEW 162

FINANCIAL INFORMATION 162

PRODUCTS 163

TABLE 90 THORATEC CARDIOVASCULAR SURGICAL PRODUCTS 163

TRANSMEDICS, INC. 163

BUSINESS OVERVIEW 163

FINANCIALS 164

PRODUCTS 164

TABLE 91 TRANSMEDICS CARDIOVASCULAR SURGICAL PRODUCTS 164

WORLDHEART CORP. 164

BUSINESS OVERVIEW 164

FINANCIAL INFORMATION 164

PRODUCTS 164

TABLE 92 WORLDHEART CARDIOVASCULAR SURGICAL PRODUCTS 165

To order this report:

Cardiovascular Devices Industry: Cardiovascular Surgical Devices: The Global Market

Cardiovascular Devices Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds Neuroprotection - Drugs, Markets and Companies
2. Reportlinker Adds Toxicology and Pharmacology
3. Reportlinker Adds Virtual Pharma
4. Reportlinker Adds Quality for Biologics
5. Reportlinker Adds Endoscopy Devices Market Outlook in Belgium to 2016 - Endoscopy Visualization Systems, Flexible and Rigid Endoscopes, Capsule Endoscope Systems and Others
6. Reportlinker Adds Japanese Market for Urological Devices 2010
7. Reportlinker Adds U.S. Market for Medical Imaging Equipment 2010
8. Reportlinker Adds Indian Bulk Drug Market
9. Reportlinker Adds Nutraceutical Market
10. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
11. Reportlinker Adds Global Top 10 Health Care Equipment Companies - Industry, Financial and SWOT Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):